GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oxford Cannabinoid Technologies Holdings PLC (LSE:OCTP) » Definitions » Net-Net Working Capital

Oxford Cannabinoid Technologies Holdings (LSE:OCTP) Net-Net Working Capital : £0.00 (As of Oct. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Oxford Cannabinoid Technologies Holdings Net-Net Working Capital?

In calculating the Net-Net Working Capital (NNWC), Benjamin Graham assumed that a company's accounts receivable is only worth 75% its value, its inventory is only worth 50% of its value, but its liabilities have to be paid in full. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. This is a conservative way of estimating the company's value.

Oxford Cannabinoid Technologies Holdings's Net-Net Working Capital for the quarter that ended in Oct. 2023 was £0.00.

The industry rank for Oxford Cannabinoid Technologies Holdings's Net-Net Working Capital or its related term are showing as below:

LSE:OCTP's Price-to-Net-Net-Working-Capital is not ranked *
in the Biotechnology industry.
Industry Median: 4.33
* Ranked among companies with meaningful Price-to-Net-Net-Working-Capital only.

Oxford Cannabinoid Technologies Holdings Net-Net Working Capital Historical Data

The historical data trend for Oxford Cannabinoid Technologies Holdings's Net-Net Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oxford Cannabinoid Technologies Holdings Net-Net Working Capital Chart

Oxford Cannabinoid Technologies Holdings Annual Data
Trend May18 May19 May20 May21 Apr23
Net-Net Working Capital
- - - 0.01 -

Oxford Cannabinoid Technologies Holdings Semi-Annual Data
May19 Nov19 May20 Nov20 May21 Nov21 Oct22 Apr23 Oct23
Net-Net Working Capital Get a 7-Day Free Trial Premium Member Only 0.01 0.01 0.01 - -

Competitive Comparison of Oxford Cannabinoid Technologies Holdings's Net-Net Working Capital

For the Biotechnology subindustry, Oxford Cannabinoid Technologies Holdings's Price-to-Net-Net-Working-Capital, along with its competitors' market caps and Price-to-Net-Net-Working-Capital data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Oxford Cannabinoid Technologies Holdings's Price-to-Net-Net-Working-Capital Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oxford Cannabinoid Technologies Holdings's Price-to-Net-Net-Working-Capital distribution charts can be found below:

* The bar in red indicates where Oxford Cannabinoid Technologies Holdings's Price-to-Net-Net-Working-Capital falls into.



Oxford Cannabinoid Technologies Holdings Net-Net Working Capital Calculation

Oxford Cannabinoid Technologies Holdings's Net-Net Working Capital (NNWC) per share for the fiscal year that ended in Apr. 2023 is calculated as

Net-Net Working Capital(A: Apr. 2023 )
=(Cash, Cash Equivalents, Marketable Securities+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(2.297+0.75 * 0+0.5 * 0-0.584
-0-0)/960.416
=0.00

Oxford Cannabinoid Technologies Holdings's Net-Net Working Capital (NNWC) per share for the quarter that ended in Oct. 2023 is calculated as

Net-Net Working Capital(Q: Oct. 2023 )
=(Cash, Cash Equivalents, Marketable Securities+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(1.134+0.75 * 1.656+0.5 * 0-0.84
-0-0)/960.416
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In calculating the Net-Net Working Capital (NNWC), Benjamin Graham assumed that a company's accounts receivable is only worth 75% its value, its inventory is only worth 50% of its value, but its liabilities have to be paid in full.

In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.

This is a conservative way of estimating the company's value.


Oxford Cannabinoid Technologies Holdings  (LSE:OCTP) Net-Net Working Capital Explanation

One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.

Benjamin Graham looked for companies whose market values were less than two-thirds of their net-net value. They are collected under our Net-Net screener.


Oxford Cannabinoid Technologies Holdings Net-Net Working Capital Related Terms

Thank you for viewing the detailed overview of Oxford Cannabinoid Technologies Holdings's Net-Net Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Oxford Cannabinoid Technologies Holdings (LSE:OCTP) Business Description

Traded in Other Exchanges
Address
267 Banbury Road, Prama House, Oxford, GBR, OX2 7HT
Oxford Cannabinoid Technologies Holdings PLC is a pharmaceutical company engaged in cannabinoid drug development. The company uses a drug development that includes proprietary cannabinoid derivatives, natural phytocannabinoids (pCBs), and in-licensed compounds. Its primary market focus is the pain market, and OCT initially aims to develop a portfolio of four drug candidates for approval as licensed pain medicines.

Oxford Cannabinoid Technologies Holdings (LSE:OCTP) Headlines

No Headlines